Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
Research Articles, Development/Plasticity/Repair

Olig2 Ablation in Immature Oligodendrocytes Does Not Enhance CNS Myelination and Remyelination

Jiajia Wang, Lijun Yang, Minqing Jiang, Chuntao Zhao, Xuezhao Liu, Kalen Berry, Ari Waisman, Abraham J. Langseth, Bennett G. Novitch, Dwight E. Bergles, Akiko Nishiyama and Q. Richard Lu
Journal of Neuroscience 9 November 2022, 42 (45) 8542-8555; https://doi.org/10.1523/JNEUROSCI.0237-22.2022
Jiajia Wang
1Department of Pediatrics, Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lijun Yang
1Department of Pediatrics, Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Minqing Jiang
1Department of Pediatrics, Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chuntao Zhao
1Department of Pediatrics, Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuezhao Liu
1Department of Pediatrics, Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kalen Berry
1Department of Pediatrics, Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ari Waisman
2Institute for Molecular Medicine, Langenbeckstrasse 1, Mainz, 55131, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abraham J. Langseth
3The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bennett G. Novitch
4Department of Neurobiology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California 90095
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dwight E. Bergles
3The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
5Johns Hopkins Kavli Neuroscience Discovery Institute, Baltimore, Maryland 21205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dwight E. Bergles
Akiko Nishiyama
6Department of Physiology and Neurobiology, University of Connecticut, Storrs, Connecticut, 06269
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Akiko Nishiyama
Q. Richard Lu
1Department of Pediatrics, Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Q. Richard Lu
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Deletion of Olig2 in OPCs inhibits OL differentiation and myelination. A, Schematic representation of Olig2 and marker expression during the OL lineage development. B, Schematic diagram for TAM administration and sample collection in Olig2+/+ control (Ctrl, Pdgfra-CreERT) and iKO-Pdgfra mice. C, Representative images of cortical sections from control (Ctrl) mice and iKO-Pdgfra mice at P14 stained for Olig2 (green) and PDGFRα (red). Scale bars, 30 µm. D, Representative images of the corpus callosum of Ctrl mice and iKO-Pdgfra mice at P14 immunostained for MBP (red) and CC1 (green). Scale bars, 50 µm. E, Quantification of Olig2+ cells (left), PDGFRα+ cells (middle), and CC1+ cells (right) in the iKO-Pdgfra mice relative to Ctrl mice at P7 and P14. n = 3 animals per group. F, Grayscale images of MBP in P14 cortical sections of Ctrl and cKO-Cnp mice. Scale bars, 1 mm. G, Electron micrograph analysis of optic nerves of Ctrl and cKO-Cnp mice at P14. Scale bars, 1 µm. H, Percentage of myelinated axons in Ctrl and cKO-Cnp optic nerves. n = 4 animals per group. I, Quantification of myelin g-ratio in the optic nerve from Ctrl and cKO-Cnp mice. More than 300 axons were counted from 4 animals per group. Data are mean ± SEM. **p < 0.01; ***p < 0.001; unpaired two-tailed Student's t test.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Deletion of Olig2 in immature OL at the neonatal stages inhibits OL maturation. A, Control (Ctrl; Plp1-CreERT) and iKO-Plp mice carrying the tdTomato reporter were given TAM daily from P5 to P9 and harvested at indicated stages. B, Representative grayscale images of cortical sections from Ctrl and iKO-Plp mice at P14 stained for MBP. Scale bars, 100 µm. C, Representative images of tdTomato (red) and staining for Olig2 (blue) and CC1 (green) cells in the cortex of Ctrl and iKO-Plp mice at P14. Arrows indicate the tdTomato+ cells. Scale bars, 30 µm. D, Percentages of tdTomato reporter+ cells in cortex that express Olig2 (left) and CC1 (right) at P14. E, Representative images of tdTomato (red) and staining for Olig2 (blue) and CC1 (green) cells in the corpus callosum of Ctrl and iKO-Plp mice at P14. Arrows indicate the tdTomato+ cells. Scale bars, 30 µm. F, Percentages of tdTomato reporter+ cells in corpus callosum that express Olig2 (left) and CC1 (right) at P14. G, Representative images of tdTomato (red) and staining for cytoplasmic Olig1 (Olig1, green) in the corpus callosum from Ctrl and iKO-Plp mice at P14. Scale bars, 20 µm. H, Left, Percentages of tdTomato+ cells in the corpus callosum with cytoplasmic staining for Olig1. Right, Total number of tdTomato+ cells and cytoplasmic Olig1+ cells in the corpus callosum per mm2 at P14. I, Representative images of GST-π immunostaining in the cortex from Ctrl and iKO-Plp mice at P14. Scale bars, 60 µm. J, Fold change of the GST-π+ cell number in the iKO-Plp mice relative to Ctrl mice at P14. K, Percentages of CC1+ cells among tdTomato+ cells in the cortices of Ctrl and iKO-Plp mice at indicated stages. n = 5 animals per genotype. Data are mean ± SEM. ***p < 0.001; **p < 0.01; unpaired two-tailed Student's t test.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Mobp- and Mog-Cre expression in postmitotic immature and mature OLs in the developing brain and spinal cord. A, Representative images of fluorescent tdTomato expression (red) in postmitotic OLs in the developing corpus callosum and spinal cord in Mobp-iCre;Rosa-tdTomato mice at P14 stained for CC1 (green) and PDGFRα (purple). Scale bars, 50 µm. B, Enlarged inset of image in A. Arrows indicate CC1+ postmitotic OLs positive for tdTomato. Arrowhead indicates PDGFRa+ OPC that does not express tdTomato. Scale bar, 20 µm. C, Representative images of fluorescent tdTomato expression (red) in postmitotic OLs in the developing corpus callosum and spinal cord in Mog-iCre;Rosa-tdTomato mice at P14 stained for CC1 (green) and PDGFRα (purple). Scale bars, 50 µm. D, Enlarged inset of the spinal cord in C. Arrows indicate CC1+ postmitotic OL cells positive for tdTomato. Arrowhead indicates PDGFRa+ OPC that does not express tdTomato. Scale bar, 20 µm.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Olig2 ablation causes maturation arrest and myelination deficits. A, Representative images of the cerebral white matter of control (Olig2fl/fl) and cKO-Mobp mice at P7 stained for MBP. Scale bars, 100 µm. B, Representative images of P7 spinal cords from control and cKO-Mobp mice immunostained for Olig2 (red) and MBP (green). Scale bars, 20 µm. C, MBP density in the brain and spinal cord of cKO-Mobp mice relative to control mice at P7. D, Representative images of the cerebral white matter of control (Olig2fl/fl) and cKO-Mog mice at P7 stained for MBP. Scale bars, 100 µm. E, Representative images of P7 spinal cords from control and cKO-Mog mice immunostained for Olig2 (red) and MBP (green). Scale bars, 100 µm. F, MBP density in the brain and spinal cord of cKO-Mog mice relative to control mice at P7. G, Representative images of P14 corpus callosum immunostained for CC1 (green) and Olig2 (red). Dotted lines indicate the subcortical white matter tracts. Scale bars, 20 µm. H, Fold change in CC1+ cell number (left) and percentage of CC1+ cells among Olig2+ cells in the cKO-Mog mice compared with control mice. I, Representative images of P14 cortex from control and cKO-Mog mice immunostained for Olig1 (red) and Olig2 (green). Scale bars, 20 µm. J, Frequency of cytoplasmic Olig1+ cells in the cortex of cKO-Mog mice relative to control mice. n = 4 animals per genotype. Data are mean ± SEM. ***p < 0.001; **p < 0.01; *p < 0.05; unpaired two-tailed Student's t test.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Olig2 deletion in mature OLs does not cause demyelination. A, Ctrl (Plp1-CreERT) and iKO-Plp adult mice (8-week-old) carrying the tdTomato reporter were administered with TAM daily for 7 d and killed at 1 (1 M) or 11 months (11 M) after TAM. B, C, Representative images of tdTomato (red), Olig2 (green), and staining for SOX10 (B) and GST-π (C) in the cortex from Ctrl and iKO-Plp mice at 1 month after TAM injection. Arrows indicate the tdTomato+ cells. Scale bars, 20 µm. D, Percentages of tdTomato+ cells in the cortex that express Olig2 (left), SOX10 (middle), and GST-π (right) in Ctrl and iKO-Plp mice. n = 3 animals per genotype. E, Representative images (left) of tdTomato (red), Olig2 (green), and staining for cleaved caspase 3 (CC3, purple) and quantifications (right, n = 3 animals per genotype) in the cortex from Ctrl and iKO-Plp mice at 1 month after TAM injection. Scale bars, 20 µm. F, Representative images of Ctrl and iKO-Plp mice cortex stained for MBP or Olig2 at 11 months after TAM injection. Scale bars, 50 µm. G, Quantifications for the area of MBP+ cells (left) and Olig2+ cells (right) in the cortex of iKO-Plp mice relative to controls. Scale bars, 20 µm. n = 3 animals per genotype. H, Representative EM images showing optic nerve and spinal cord in the Ctrl and iKO-Plp brains at 11 months after TAM injection. Scale bars, 2 µm. I, Quantification of myelin g-ratio in the optic nerve (left) and spinal white matter (right) from Ctrl and iKO-Plp mice. More than 150 axons were counted from 3 animals per group. n = 3 animals per genotype. Data are mean ± SEM. **p < 0.01; *p < 0.05; unpaired two-tailed Student's t test.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Olig2 activates the transcriptional program required for OL maturation from iOL. A, Visualization of Olig2 and H3k27ac occupancy on representative genes involved in transcriptional regulation in immature OLs and maturing OLs. B, Visualization of Olig2 and H3k27ac occupancies on representative myelin gene loci in immature OLs and mature OLs. C, Left, Representative images of Ctrl (Plp1-CreERT) and iKO-Plp brains at P14 stained for ASPA. Scale bars, 50 µm. Right, Fold change in ASPA+ cell frequency. n = 5 animals per genotype. D, Representative images of coronal sections from Ctrl and iKO-Plp cortices at P14 immunostained for Sox10. Scale bars, 50 µm. E, Representative images of the cortex of tdTomato (red) and staining for Sox10 (green) in Ctrl and iKO-Plp mice at P14. Arrows indicate the tdTomato+ cells. Scale bars, 50 µm. F, Left, Fold change in Sox10+ cell frequency (left) and the percentage of tdTomato+ cells that express SOX10 (right) in the cortex of cKO-Plp mice relative to Ctrl mice. n = 5 animals per genotype. Data are mean ± SEM. ***p < 0.001; **p < 0.01; unpaired two-tailed Student's t test.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Olig2 is required for CNS remyelination. A, TAM treatment scheme for LPC-induced demyelination in the spinal white matter of Ctrl (Plp1-CreERT) and iKO-Plp mice carrying the tdTomato reporter. B, C, Representative images of spinal LPC lesions (dashed lines) of Ctrl and iKO-Plp mice at dpi 3 stained for MBP (green) and DAPI (blue). C, Relative lesion size and MBP+ areas. Dashed lines indicate the DAPI dense lesion sites. Scale bars, 20 µm. D, Representative images of spinal LPC lesions (dashed lines) of Ctrl and iKO-Plp mice at dpi 21 stained for Olig2 (green) and CC1 (blue). Scale bars, 20 µm. E, Fold change in Olig2+ (left) and CC1+ cell (right) frequencies in the cKO-Plp mice relative to Ctrl mice at dpi 14 and 21. F, Left, Representative images of spinal LPC lesions (dashed lines) of Ctrl and iKO-Plp mice at dpi 21 stained for MBP (green) and with DAPI to mark nuclei (blue). Scale bars, 20 µm. Right, Relative intensity of MBP staining in spinal LPC lesions of Ctrl and iKO-Plp mice at dpi 14 and 21. G, ISH for Plp1 mRNA in spinal LPC lesions (dashed lines) of Ctrl and iKO-Plp mice at dpi 14 and 21. Scale bars, 50 µm. H, Quantification of Plp1+ OLs in spinal LPC lesions of Ctrl and iKO-Plp at dpi 14 and 21. I, Left, Representative images of cross semithin sections of LPC lesions (dashed lines) stained with toluidine blue (scale bars, 20 µm) and transmission electron microscopy images (scale bars, 2 µm) from Ctrl and iKO-Plp mice. Right, Percentages of axons that are myelinated in spinal LPC lesions of Ctrl and iKO-Plp mice at dpi 14. n = 5 animals per genotype. Data are mean ± SEM. ***p < 0.001; **p < 0.01; unpaired two-tailed Student's t test.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Olig2 controls a regulatory network required for OL differentiation. A, GSEA of spinal LPC lesions of Ctrl (Plp1-CreERT) and iKO-Plp mice. NES, Net enrichment score. B, GSEA plot of OL markers and CNS demyelination genes in Ctrl and iKO-Plp lesions. C, Heatmap representing mature OL gene program in spinal LPC lesions of Ctrl and iKO-Plp mice. Genes (p < 0.05, fold change > 1.5) were considered as differentially expressed genes (DEGs). D, qRT-PCR analysis of representative mature OL genes that are differentially expressed in iKO-Plp lesions. E, Heatmap representing OPC-enriched gene program in spinal LPC lesions of Ctrl and iKO-Plp mice. F, Expression of OPC enriched genes from the transcriptomics of the LPC lesions of Ctrl and iKO-Plp mice. G, GSEA plot of neural precursor cell proliferation program in Ctrl and iKO-Plp lesions. n = 3 animals per genotype. Data are mean ± SEM. ***p < 0.001; **p < 0.01; *p < 0.05; unpaired two-tailed Student's t test.

Back to top

In this issue

The Journal of Neuroscience: 42 (45)
Journal of Neuroscience
Vol. 42, Issue 45
9 Nov 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Masthead (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Olig2 Ablation in Immature Oligodendrocytes Does Not Enhance CNS Myelination and Remyelination
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Olig2 Ablation in Immature Oligodendrocytes Does Not Enhance CNS Myelination and Remyelination
Jiajia Wang, Lijun Yang, Minqing Jiang, Chuntao Zhao, Xuezhao Liu, Kalen Berry, Ari Waisman, Abraham J. Langseth, Bennett G. Novitch, Dwight E. Bergles, Akiko Nishiyama, Q. Richard Lu
Journal of Neuroscience 9 November 2022, 42 (45) 8542-8555; DOI: 10.1523/JNEUROSCI.0237-22.2022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Olig2 Ablation in Immature Oligodendrocytes Does Not Enhance CNS Myelination and Remyelination
Jiajia Wang, Lijun Yang, Minqing Jiang, Chuntao Zhao, Xuezhao Liu, Kalen Berry, Ari Waisman, Abraham J. Langseth, Bennett G. Novitch, Dwight E. Bergles, Akiko Nishiyama, Q. Richard Lu
Journal of Neuroscience 9 November 2022, 42 (45) 8542-8555; DOI: 10.1523/JNEUROSCI.0237-22.2022
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • demyelination
  • myelination
  • Olig2
  • oligodendrocyte lineage
  • remyelination
  • white matter injury

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Articles

  • Dynamic respiration-neural coupling in substantia nigra across sleep and anesthesia
  • Presynaptic trafficking of Glutamate Decarboxylase isoforms is dispensable for basal GABAergic neurotransmission
  • Increased perceptual reliability reduces membrane potential variability in cortical neurons
Show more Research Articles

Development/Plasticity/Repair

  • Temporal and Spatial Scales of Human Resting-state Cortical Activity Across the Lifespan
  • Activity Deprivation Modulates the Shank3/Homer1/mGluR5 Signaling Pathway to Enable Synaptic Upscaling
  • IGFBP2–Ceramide Pathway Mediates Divergent Myelin Breakdown in the PNS and CNS Following Injury
Show more Development/Plasticity/Repair
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.